122 related articles for article (PubMed ID: 6217211)
1. Glucocorticoid influence on growth of vascular wall cells in culture.
Longenecker JP; Kilty LA; Johnson LK
J Cell Physiol; 1982 Nov; 113(2):197-202. PubMed ID: 6217211
[TBL] [Abstract][Full Text] [Related]
2. Proliferative variability of endothelial clones derived from adult bovine aorta: influence of fibroblast growth factor and smooth muscle cell extracellular matrix.
Longenecker JP; Kilty LA; Ridge JA; Miller DC; Johnson LK
J Cell Physiol; 1983 Jan; 114(1):7-15. PubMed ID: 6219118
[TBL] [Abstract][Full Text] [Related]
3. In vitro proliferation and lifespan of bovine aorta endothelial cells: effect of culture conditions and fibroblast growth factor.
Duthu GS; Smith JR
J Cell Physiol; 1980 Jun; 103(3):385-92. PubMed ID: 6447157
[TBL] [Abstract][Full Text] [Related]
4. Effect of substrata and fibroblast growth factor on the proliferation in vitro of bovine aortic endothelial cells.
Gospodarowicz D; Lui GM
J Cell Physiol; 1981 Oct; 109(1):69-81. PubMed ID: 6460040
[TBL] [Abstract][Full Text] [Related]
5. Control of proliferation of bovine vascular endothelial cells.
Gospodarowicz D; Moran JS; Braun DL
J Cell Physiol; 1977 Jun; 91(3):377-85. PubMed ID: 301144
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of antibody against basic fibroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture.
Lu J; Nishizawa Y; Tanaka A; Nonomura N; Yamanishi H; Uchida N; Sato B; Matsumoto K
Cancer Res; 1989 Sep; 49(18):4963-7. PubMed ID: 2766270
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional alterations in the surface of vascular endothelial cells associated with the formation of a confluent cell monolayer and with the withdrawal of fibroblast growth factor.
Vlodavsky I; Gospodarowicz D
J Supramol Struct; 1979; 12(1):73-114. PubMed ID: 232528
[TBL] [Abstract][Full Text] [Related]
8. Proliferation of Shionogi carcinoma 115 cells by glucocorticoid-induced autocrine heparin-binding growth factor(s) in serum-free medium.
Yamanishi H; Nonomura N; Tanaka A; Nishizawa Y; Terada N; Matsumoto K; Sato B
Cancer Res; 1991 Jun; 51(11):3006-10. PubMed ID: 2032238
[TBL] [Abstract][Full Text] [Related]
9. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
[TBL] [Abstract][Full Text] [Related]
11. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.
Dodge AB; Lu X; D'Amore PA
J Cell Biochem; 1993 Sep; 53(1):21-31. PubMed ID: 8227180
[TBL] [Abstract][Full Text] [Related]
12. Interactions between cultured bovine arterial smooth muscle cells and endothelial cells; studies on the release of growth inhibiting and growth stimulating factors.
Xu CB; Falke P; Stavenow L
Artery; 1990; 17(6):297-310. PubMed ID: 2248558
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 2 uses distinct signaling pathways for cell proliferation and cell shape changes in corneal endothelial cells.
Gu X; Seong GJ; Lee YG; Kay EP
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2326-34. PubMed ID: 8843917
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction of interleukin-1 beta and growth factors in primary cultures of rat aortic smooth muscle cells.
Bourcier T; Dockter M; Hassid A
J Cell Physiol; 1995 Sep; 164(3):644-57. PubMed ID: 7544359
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor upregulates PGG/H synthase in rabbit microvascular endothelial cells by a glucocorticoid independent mechanism.
Moatter T; Gerritsen ME
J Cell Physiol; 1992 Jun; 151(3):571-8. PubMed ID: 1295904
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid inhibition of vascular smooth muscle cell proliferation: influence of homologous extracellular matrix and serum mitogens.
Longenecker JP; Kilty LA; Johnson LK
J Cell Biol; 1984 Feb; 98(2):534-40. PubMed ID: 6693494
[TBL] [Abstract][Full Text] [Related]
17. The effects of endothelial cell-conditioned media on the proliferation of aortic smooth muscle cells and 3T3 cells in culture.
Wang CH; Largis EE; Schaffer SA
Artery; 1981; 9(5):358-71. PubMed ID: 6976159
[TBL] [Abstract][Full Text] [Related]
18. A novel recombinant basic fibroblast growth factor and its secretion.
Sohn YD; Lim HJ; Hwang KC; Kwon JH; Park HY; Chung KH; Cho SY; Jang Y
Biochem Biophys Res Commun; 2001 Jun; 284(4):931-6. PubMed ID: 11409882
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) system members in bovine corpus luteum endothelial cells during treatment with FGF-2, VEGF or oestradiol.
Gabler C; Plath-Gabler A; Killian GJ; Berisha B; Schams D
Reprod Domest Anim; 2004 Oct; 39(5):321-7. PubMed ID: 15367264
[TBL] [Abstract][Full Text] [Related]
20. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.
Mohacsi PJ; Tüller D; Hulliger B; Wijngaard PL
J Heart Lung Transplant; 1997 May; 16(5):484-92. PubMed ID: 9171265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
